¿Â¶óÀμ­Á¡

ÄíÆùÀÎÁõ¼¾ÅÍ

¿Â¸®¿øÀ̺¥Æ®

µµÀü! ÃâÁ¦¿Õ Ç®ÀÌ¿Õ

  • ¿ì¸®°¡ ¸¸µé°í ¿ì¸®°¡ Ç®¾îº¸´Â Èï¹ÌÁøÁøÇÑ ÄûÁî¹æ!
  • ÃâÁ¦¿Õ, Ç®À̿տ¡ µµÀüÇϼ¼¿ä! ¹®Á¦¸¦ ÃâÁ¦ÇÏ¿© äÅÃÀÌ µÇ¸é ¾¾¾ÑÁö¼ö 10Á¡À» ±×¸®°í ¹®Á¦¸¦ ¸ÂÃß¸é ¾¾¾ÑÁö¼ö 1Á¡À» °¢°¢ Àû¸³ÇØ µå¸³´Ï´Ù.
  • ÄûÁî ÃâÁ¦ ¹× Ç®ÀÌ´Â ÇÏ·ç ÃÖ´ë 1ÀÎ 5ȸ±îÁö Âü¿©°¡ °¡´ÉÇÕ´Ï´Ù.
  • ¹®Á¦ ÃâÁ¦ÀÏ ±âÁØ ÃÖ±Ù 1³â À̳»¿¡ ÃâÁ¦µÈ ¹®Á¦¿Í À¯»çÇϰųª µ¿ÀÏÇÒ ½Ã Å»¶ô ó¸® µË´Ï´Ù.

´ÔÀÇ 10¿ù Âü¿©ÇöȲ!   ÃâÁ¦ : 0°³   Ç®ÀÌ : 0°³   Á¤´ä·ü : 0% ¹®Á¦ÃâÁ¦ÇÏ·¯Go
Q [Áß2|±âŸ] ´ÙÀ½Áß À½ÀÌ ´Ù¸¥ ÇÑÀÚ´Â?
  • çÛ
  • çÜ
  • Ѧ
  • çß
ÃÑ Âü¿©ÀÚ: 1865¸í  Á¤´äÀÚ: 769¸í  Á¤´äÀ²: 41%
Á¤´äÈ®ÀÎ
10¿ùÀÇ ÃâÁ¦¿Õ
    ÇØ´ç ȸ¿øÀÌ ¾ø½À´Ï´Ù.
10¿ùÀÇ Ç®ÀÌ¿Õ
    ÇØ´ç ȸ¿øÀÌ ¾ø½À´Ï´Ù.
2025.10.01 22:18 ±âÁØ ÀÚ¼¼È÷º¸±â
¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
80102 [Áß2|¿µ¾î] ethicalÀº À±¸®ÀûÀÎÀ̶ó´Â ¶æ ¹ÚÁ¤¿¬ 21.09.10 23
80101 [Áß2|¿µ¾î] abstruse´Â ³­ÇØÇÑÀ̶ó´Â ¶æ ¹ÚÁ¤¿¬ 21.09.10 19
80100 [Áß2|¿µ¾î] argument´Â ÁÖÀå, ³í°Å¶ó´Â ¶æ ¹ÚÁ¤¿¬ 21.09.10 15
80099 [Áß2|¿µ¾î] martyrÀº ¼ø±³ÀÚ¶ó´Â ¶æ ¹ÚÁ¤¿¬ 21.09.10 16
80098 [Áß1|¿µ¾î] provide forÀº ÁغñÇÏ´Ù ±è¼ºÇö 21.09.10 12
80097 [Áß1|¿µ¾î] supply´Â °ø±ÞÇÏ´Ù ±è¼ºÇö 21.09.10 15
80096 [Áß1|¿µ¾î] criticalÀº ºñÆÇÀûÀÎ ±è¼ºÇö 21.09.10 9
80095 [Áß1|¿µ¾î] crises´Â À§±â ±è¼ºÇö 21.09.10 11
80094 [Áß1|¿µ¾î] groupÀº ¹«¸® ±è¼ºÇö 21.09.10 21
80093 [Áß2|¿µ¾î] atherosclerosis´Â ¾ÆÅ×·Ò¼º µ¿¸Æ °æÈ­ÁõÀ̶õ ¶æÀÌ´Ù. ±èÀ±¼Ö 21.09.10 21
80092 [Áß2|¿µ¾î] neurodegenerative´Â ½Å°æº¯¼ºÀǶõ ¶æÀÌ´Ù. ±èÀ±¼Ö 21.09.10 13
80091 [Áß2|¿µ¾î] degenerativeÀº ÅðÇ༺ÀǶõ ¶æÀÌ´Ù. ±èÀ±¼Ö 21.09.10 12
80090 [Áß2|¿µ¾î] inflammatory´Â ¼±µ¿ÀûÀÎÀ̶õ ¶æÀÌ´Ù. ±èÀ±¼Ö 21.09.10 12
80089 [Áß2|¿µ¾î] malignancy´Â ¾ÏÀ̶õ ¶æÀÌ´Ù. ±èÀ±¼Ö 21.09.10 16
80088 [Áß1|¿µ¾î] enrichment´Â dzºÎÇÏ°Ô ÇÔ, ºñ¿ÁÈ­ ±è¼ºÇö 21.09.09 10
¹®Á¦ ÃâÁ¦Çϱâ
ÃÊµî ¹«·áüÇè_10¿ùÁßµî ¹«·áüÇè_11¿ù